![Cyrille Leperlier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cyrille Leperlier
Director/Board Member at
NUCANA PLC
Net worth: - $ as of 31/03/2024
Profile
Cyrille Raymond George Leperlier is currently an Independent Non-Executive Director at NuCana Plc since 2018.
Formerly, the role of Chief Executive Officer was held at Divlal SAS from 2020 to 2022.
The position of Medical Director was held at Rhone-Poulenc Rorer, Inc. Medical Director at Sanofi-Aventis Japan was held from 2014 to 2019.
Education includes graduate and doctorate degrees from the University of Paris Jussieu.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NUCANA PLC -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cyrille Leperlier active positions
| Companies | Position | Start |
|---|---|---|
| NUCANA PLC | Director/Board Member | 01/05/2018 |
Former positions of Cyrille Leperlier
| Companies | Position | End |
|---|---|---|
Divlal SAS | Chief Executive Officer | 01/11/2022 |
Sanofi-Aventis Japan | Chief Tech/Sci/R&D Officer | 01/12/2019 |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Chief Tech/Sci/R&D Officer | - |
Training of Cyrille Leperlier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
University of Paris Jussieu
 University of Paris Jussieu Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Japan | |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Divlal SAS |
- Stock Market
- Insiders
- Cyrille Leperlier
